CHGCF News and Press, Chugai Pharmaceutical From 04/22/21

Chugai Pharmaceutical (CHGCF): Q1 GAAP EPS of ¥28.82.Revenue of ¥168.82B (-5.9% Y/Y).Shares +0.79% PM.Press Release For further details see: Chugai Pharmaceutical beats on revenue

Chugai Pharmaceutical experienced unexpected demand for the drug Actemra during the pandemic, but sales appear to have peaked in FY12/2020. New releases such as Hemlibra should begin to scale in FY12/2021, together with distribution sales of Roche's Tecentriq. The company has a st...

Chugai Pharmaceutical (CHGCF) has in-licensed the rights for Atea Pharmaceuticals' (AVIR) AT-527 for the treatment of COVID-19 in Japan from Roche (RHHBY).Roche and Atea are jointly developing AT-527 for COVID-19 and Roche has the right to commercialize AT-527 outside U.S. The compa...

Chugai Pharmaceutical Co., Ltd. (CHGCF) Q4 2020 Earnings Conference Call February 04, 2021 04:00 AM ET Company Participants Tatsuro Kosaka - Chairman & Chief Executive Officer Toshiaki Itagaki - Executive Vice President & Chief Financial Officer Tomoyuki Igawa - Chief Executive Office...

The following slide deck was published by Chugai Pharmaceutical Co., Ltd. in conjunction with their 2020 Q4 earnings call. For further details see: Chugai Pharmaceutical Co., Ltd. 2020 Q4 - Results - Earnings Call Presentation

Chugai Pharmaceutical Co Ltd (CHGCF) Q3 2020 Earnings Conference Call October 22, 2020, 05:00 ET Company Participants Toshiaki Itagaki - CFO Minoru Hirose - Department Manager, R&D Portfolio Management Dept. Shinji Hidaka - VP & Head, Marketing & Sales Division Conference Call Par...

The following slide deck was published by Chugai Pharmaceutical Co., Ltd. in conjunction with their 2020 Q3 earnings call. For further details see: Chugai Pharmaceutical Co., Ltd. 2020 Q3 - Results - Earnings Call Presentation

Chugai Pharmaceutical (CHGCF): Q3 GAAP EPS of -SEK0.72.Revenue of SEK14.48B (-23.1% Y/Y)Press Release For further details see: Chugai Pharmaceutical reports Q3 results

Chugai Pharmaceutical Co. Ltd (CHGCF) Half Year 2020 Earnings Conference Call July 27, 2020 4:00 AM ET Company Participants Tatsuro Kosaka – Chairman and Chief Executive Officer Toshiaki Itagaki – Chief Financial Officer Minoru Watanabe – Vice President, Head...

The following slide deck was published by Chugai Pharmaceutical Co., Ltd. in conjunction with their 2020 Q2 earnings Read more ...